It may pay for us to do some research on Osiris and its product,...

It may pay for us to do some research on Osiris and its product, as well as re-read the life scientist material and compare data. From memory Osiris objective for Phase 2 trial was met?
Agree positive/great news would be in our favour.

Just a few snippets not comprehensive as it is late and I should be in bed!


http://www.osiris.com/prod_diabetes.php - Pre-clinical studies first conducted by researchers at Genzyme found that MSCs may have the ability to delay the progression of type 1 diabetes by preserving beta cell function.

http://www.osiris.com/clinical_prochymal_t1dm.php The objective of this Phase 2 study is to evaluate the efficacy and safety of Prochymal in those patients who have been recently diagnosed with type 1 diabetes mellitus (T1DM). T1DM, or juvenile diabetes, is an autoimmune disorder where the immune system attacks and destroys the beta cell

http://www.lifescientist.com.au/article/407018/mesoblast_posts_successful_results_from_diabetes_stem_cell_trial/
“Intravenous injection of our MPCs may not only improve blood glucose control, it may concomitantly reduce the significant risk of heart attacks and death that occurs in patients with Type 2 diabetes,” said Mesoblast CEO, Professor Silviu Itescu. in the pancreas.